RIFAMPICIN RESISTANT TUBERCULOSIS IN THAI NGUYEN

Hoàng Hà, Lưu Thị Thu Uyên, Ngô Thị Hoài

Main Article Content

Abstract

Objectives: to characterize the clinical situation and analyze a number of factors related to treatment outcomes for RR-TB. Methods: Descriptive study at Thai Nguyen Hospital of Tuberculosis and Lung Disease, from 2016 - 2020. Sample of all patients tested for Xpert MTB / RIF with RR-TB on standard regimen 11 months 4-6 Km Lfx Pto Cfz ZH high dose E / 5 Lfx Cfz Z E. Results: 948/4187 (22.6%) Mtb / Rif (+), obtained 83/948 (8.8%), RR-TB sourced the new TB form was 27/675 (4%); The previous antiTB treatment form was 43/215 (20%) and the extrapulmonary form was 13/58 (1.2%). There were 60 (72.3%) RR-TB on the 11-month regimen. Good outcome of treatment is 48 (80%) and poor is 12 (20%). Conclusions: RR-TB was more common in the middle-aged group, previous antiTB treatment, (AFB) smear-positive sputum, extensive lung X-ray lesions. Factors that affect poorly on treatment outcomes were: previous antiTB treatment, rales in lungs sound, smear-positive sputum and cavitary disease.

Article Details

References

1. Bộ Y tế, (2018), Hướng dẫn chẩn đoán, điều trị và dự phòng bệnh lao, Quyết định số 3126/QĐ – BYT.
2. Liu CH, Li L, Chen Z, Wang Q, Hu YL, et al. (2011), Characteristics and Treatment Outcomes of Patients with MDR and XDR Tuberculosis in a TB Referral Hospital in Beijing: A 13-Year Experience. PLoS ONE 6(4): e19399. doi:10.1371/ journal. pone.0019399.
3. Monadil H Ali, et al.2019, “Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications”, pp 6.
4. Orina GM, et al., (2017), Comparative Study of Smear Microscopy, Gene Xpert and Culture and Sensitivity Assays in Detection of Mycobacterium tuberculosis on Sputum Samples among Tuberculosis Suspected Cases in Nyamira County Referral Hospital, University Nairobi, Kenya, Mycobact Dis 2017, 7:3 DOI: 10.4172/2161-1068.1000249.
5. Tang S, Tan S, Yao L, Li F, Li L, et al. (2013), Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation. PLoS ONE 8(12): e82943.doi:10.1371/journal.pone.0082943
6. WHO (2019), Global tuberculosis report 2019, pp 3, 58.